Publications by authors named "J L Rubin"

is one of the most important bacteria responsible for clinical bovine mastitis globally, leading to significant economic losses in the dairy industry. Antimicrobials used to treat and prevent mastitis can lead to antimicrobial resistance (AMR) in . We retrospectively evaluated AMR of isolates from clinical bovine mastitis cases submitted to the Animal Health Centre in British Columbia from 2013 to May 2024.

View Article and Find Full Text PDF

Secondary lymphedema is a common complication following surgical treatment of solid tumors. Although more prevalent in women due to higher breast cancer rates, men also develop lymphedema, often with more severe manifestations. Despite these differences in clinical presentation, the cellular mechanisms underlying sex differences are poorly understood.

View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with a poor prognosis despite aggressive therapy. Here, we hypothesized that daily host signaling regulates tumor growth and synchronizes circadian rhythms in GBM. We find daily glucocorticoids promote or suppress GBM growth through glucocorticoid receptor (GR) signaling depending on time of day and the clock genes, Bmal1 and Cry.

View Article and Find Full Text PDF

Background: Pain is common in patients with chronic liver disease. Our limited understanding of patterns and severity of pain in this population hinders the development of effective cirrhosis-specific pain management strategies.

Methods: Using cross-sectional data from the 2016-2021 National Health Interview Survey, we examined rates, severity, and functional limitations due to pain in respondents with liver disease (viral hepatitis, cirrhosis, and liver cancer), compared to the general population and those with other chronic conditions associated with pain (ie, arthritis, diabetes, and chronic kidney disease).

View Article and Find Full Text PDF
Article Synopsis
  • Patients undergoing abdominal-based free flap breast reconstruction face a risk of venous thromboembolism (VTE), and the study tested if a standardized anticoagulation protocol could reduce this risk.
  • A retrospective review analyzed 2,317 patients, comparing outcomes between those treated before and after implementing an enhanced recovery after surgery (ERAS) protocol in 2015, which included enoxaparin for different durations based on body mass index (BMI).
  • The results showed low VTE rates in both groups with no significant differences, but the ERAS cohort had notably lower flap failure rates, indicating that the new protocol was effective without increasing other complications.
View Article and Find Full Text PDF